Similarly, radiotherapy has emerged as a potent immunomodulator in osteosarcoma by promoting antigen release, increasing tumor immunogenicity, and upregulating immune checkpoint molecule expression such as PD-L1 (81). This evidence concerns the gene CD274 and neoplasm.